BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• BioMidwest

  IceCure Medical Ltd. Announces Commencement Of ICE3 Clinical Trial For Breast Cancer

  May 2, 2014

   · 

  3 min read
• Business

  IMPAX Laboratories, Inc. Reports First Quarter 2014 Results

  May 2, 2014

   · 

  1 min read
• Policy

  Back To The Drawing Board For The Medicines Company, As The FDA Denies Antiplatelet Agent Cangrelor

  May 2, 2014

   · 

  6 min read
• Deals

  Santa Clara’s ProteinSimple Files Registration Statement For Proposed IPO

  May 2, 2014

   · 

  2 min read
• Drug Development

  Vertex Pharmaceuticals (MA) Release: Addition Of VX-661 To KALYDECO® (Ivacaftor) Improves Lung Function In People With CF Who Are Heterozygous For The F508del And G551D Mutations In 28-Day Phase 2 Proof-Of-Concept Study

  May 2, 2014

   · 

  1 min read
• Policy

  Masimo Corporation Reverses Whistleblowers’ $5.4 Million Reward

  May 2, 2014

   · 

  1 min read
• Deals

  After Three Delays, SCYNEXIS, Inc. Finally Goes IPO At $10 A Share

  May 2, 2014

   · 

  2 min read
• Drug Development

  Endocyte, Inc., Merck & Co., Inc. Halt Study Of Ovarian Cancer Drug Vintafolide; Endocyte Stock Plunges -61.91% At Market Close (May 2, 2014)

  May 2, 2014

   · 

  9 min read